paclitaxel has been researched along with Elevated Cholesterol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, C; Mei, H; Zheng, X; Zhou, M | 1 |
Chew, I; Park, KJ; Soslow, RA | 1 |
Hamamdzic, D; Huibregtse, BA; Keane, MG; Llano, R; Patel, DB; Seifert, PS; Wang, H; Wilensky, RL; Wilson, GJ; Winsor-Hines, D | 1 |
Arampatzis, CA; de Feyter, PJ; Hoye, A; Lemos, PA; McFadden, E; Ong, AT; Serruys, PW; Sianos, G; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
4 other study(ies) available for paclitaxel and Elevated Cholesterol
Article | Year |
---|---|
Rescuing Impaired Re-endothelialization of Drug-Eluting Stents Using the Hepatocyte Growth Factor.
Topics: Angioplasty, Balloon; Animals; Apoptosis; Cardiovascular Agents; Carotid Arteries; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Endothelial Progenitor Cells; Hepatocyte Growth Factor; Hypercholesterolemia; Injections, Subcutaneous; Male; Neointima; Paclitaxel; Rabbits; Re-Epithelialization; Time Factors | 2016 |
Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cystadenocarcinoma, Serous; Diagnosis, Differential; Female; Humans; Hypercholesterolemia; Hypertension; Immunohistochemistry; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant | 2009 |
Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries.
Topics: Animals; Blood Vessel Prosthesis Implantation; Cell Movement; Coronary Artery Disease; Coronary Vessels; Diabetes Complications; Disease Progression; Drug-Eluting Stents; Humans; Hypercholesterolemia; Inflammation; Models, Animal; Neointima; Paclitaxel; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; T-Lymphocytes | 2011 |
Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Brachytherapy; Cohort Studies; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Incidence; Male; Middle Aged; Paclitaxel; Radiography; Recurrence; Sirolimus; Stents; Treatment Outcome | 2004 |